Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pamiteplase

Known as: 275-L-Glutamic Acid-(1-91)-(174-527)-Plasminogen Activator (Human Tissue-Type Protein Moiety) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
First generation thrombolytics (streptokinase and urokinase) had no fibrin binding capabilities and caused systemic plasminogen… Expand
2008
2008
The tissue plasminogen activator analogue (pamiteplase) gene was introduced into CHO cells, and several methotorexate (MTX… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 4
2003
2003
Abstract Using a rat model of thromboembolic stroke we evaluated whether or not fibrinolysis by bolus injection of pamiteplase, a… Expand
2001
2001
The effects of alteplase (tissue plasminogen activator, t-PA) and pamiteplase (a modified t-PA with longer half-life and… Expand
2001
2001
The pharmacokinetics of pamiteplase and recombinant tissue-type plasminogen activator (rt-PA) in rats, dogs, and monkeys were… Expand
Review
2000
Review
2000
  • M. Verstraete
  • The American journal of medicine
  • 2000
  • Corpus ID: 1033227
Several third-generation thrombolytic agents have been developed. They are either conjugates of plasminogen activators with… Expand
2000
2000
The pharmacokinetics of pamiteplase in rats was compared with the pharmacokinetics of recombinant wild-type tissue-type… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
2000
2000
1. An enzyme-linked immunosorbent assay (ELISA) and functional bioassay to determine immunoreactive and bioactive concentrations… Expand
1999
1999
The monosaccharides (neutral and amino sugars) of palmiteplase (recombinant modified human tissue plasminogen activator) were… Expand
1997
1997
Single and repeated intravenous toxicity studies of Pamiteplase (genetical recombination) YM866, a novel recombinant human tissue… Expand